These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36689665)

  • 1. Retention and Predictors of Attrition Among HIV-infected Children on Antiretroviral Therapy in Côte d'Ivoire Between 2012 and 2016.
    Touré F; Etheredge GD; Brennan C; Parris K; Diallo MO; Ouffoue AF; Ekra A; Prao H; Assamoua NV; Gnongoue C; Kone F; Koffi C; Kamagaté F; Rivadeneira E; Carpenter D
    Pediatr Infect Dis J; 2023 Apr; 42(4):299-304. PubMed ID: 36689665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral treatment response of HIV-infected children after prevention of mother-to-child transmission in West Africa.
    Ndondoki C; Dicko F; Ahuatchi Coffie P; Kassi Eboua T; Ekouevi DK; Kouadio K; Edmond Aka A; Malateste K; Dabis F; Amani-Bosse C; Toure P; Leroy V;
    J Int AIDS Soc; 2014; 17(1):18737. PubMed ID: 24894377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.
    Anaky MF; Duvignac J; Wemin L; Kouakoussui A; Karcher S; Touré S; Seyler C; Fassinou P; Dabis F; N'Dri-Yoman T; Anglaret X; Leroy V
    Bull World Health Organ; 2010 Jul; 88(7):490-9. PubMed ID: 20616968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of HIV infection on access to cancer care and survival among women with invasive cervical cancer in Côte d'Ivoire: A prospective cohort study.
    Boni SP; Horo A; Didi-Kouko-Coulibaly J; Tanon A; Tchounga BK; Coffie PA; Comoe JC; Moh RD; Dabis F; Adoubi I; Jaquet A;
    Int J Gynaecol Obstet; 2023 Nov; 163(2):392-401. PubMed ID: 37350012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.
    Losina E; Touré H; Uhler LM; Anglaret X; Paltiel AD; Balestre E; Walensky RP; Messou E; Weinstein MC; Dabis F; Freedberg KA; ;
    PLoS Med; 2009 Oct; 6(10):e1000173. PubMed ID: 19859538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.
    Desmonde S; Coffie P; Aka E; Amani-Bosse C; Messou E; Dabis F; Alioum A; Ciaranello A; Leroy V
    BMC Infect Dis; 2011 Jun; 11():182. PubMed ID: 21699728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Task-sharing with nurses to enhance access to HIV treatment in Côte d'Ivoire.
    McNairy ML; Bashi JB; Chung H; Wemin L; Lorng MA; Brou H; Nioble C; Lokossue A; Abo K; Achi D; Ouattara K; Sess D; Sanogo PA; Ekra A; Ettiegne-Traore V; Diabate CJ; Abrams EJ; El-Sadr WM
    Trop Med Int Health; 2017 Apr; 22(4):431-441. PubMed ID: 28101954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and health care resource utilization in HIV-infected children after antiretroviral therapy initiation in Côte d'Ivoire, 2004-2009.
    Desmonde S; Essanin JB; Aka AE; Messou E; Amorissani-Folquet M; Rondeau V; Ciaranello A; Leroy V
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):e95-103. PubMed ID: 24525473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study.
    Harouna AM; Amorissani-Folquet M; Eboua FT; Desmonde S; N'Gbeche S; Aka EA; Kouadio K; Kouacou B; Malateste K; Bosse-Amani C; Ahuatchi Coffie P; Leroy V;
    BMC Infect Dis; 2015 Aug; 15():317. PubMed ID: 26248711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pre-ART laboratory screening to identify renal, hepatic and haematological abnormalities in Côte d'Ivoire.
    Minchella PA; Adjé-Touré C; Zhang G; Tehe A; Hedje J; Rottinghaus ER; Natacha K; Diallo K; Ouedraogo GL; Nkengasong JN
    Trop Med Int Health; 2020 Apr; 25(4):408-413. PubMed ID: 31960558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results from a rapid national assessment of services for the prevention of mother-to-child transmission of HIV in Côte d'Ivoire.
    Granato SA; Gloyd S; Robinson J; Dali SA; Ahoba I; Aka D; Kouyaté S; Billy DA; Kalibala S; Koné A
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20838. PubMed ID: 27443269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity in HIV-1-Infected children treated or not treated with highly active antiretroviral therapy (HAART), Abidjan, Cote d'Ivoire, 2000-04.
    Walenda C; Kouakoussui A; Rouet F; Wemin L; Anaky MF; Msellati P
    J Trop Pediatr; 2009 Jun; 55(3):170-6. PubMed ID: 19066169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.
    Harambat J; Fassinou P; Becquet R; Touré P; Rouet F; Dabis F; Msellati P; Blanche S; Timité-Konan M; Salamon R; Leroy V;
    BMC Public Health; 2008 May; 8():169. PubMed ID: 18492259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.
    Desmonde S; Avit D; Petit J; Amorissani Folquet M; Eboua FT; Amani Bosse C; Dainguy E; Mea V; Timite-Konan M; Ngbeché S; Ciaranello A; Leroy V
    PLoS One; 2016; 11(12):e0166466. PubMed ID: 27935971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire.
    Auld AF; Tuho MZ; Ekra KA; Kouakou J; Shiraishi RW; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):381-7. PubMed ID: 24670690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire.
    Pasquet A; Messou E; Gabillard D; Minga A; Depoulosky A; Deuffic-Burban S; Losina E; Freedberg KA; Danel C; Anglaret X; Yazdanpanah Y
    PLoS One; 2010 Oct; 5(10):e13414. PubMed ID: 20976211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peer Recruitment Strategies for Female Sex Workers Not Engaged in HIV Prevention and Treatment Services in Côte d'Ivoire: Program Data Analysis.
    Olawore O; Astatke H; Lillie T; Persaud N; Lyons C; Kamali D; Wilcher R; Baral S
    JMIR Public Health Surveill; 2020 Oct; 6(4):e18000. PubMed ID: 33001039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.